Guardant Health, Inc.
GH · Large Cap · NASDAQ · Healthcare · Diagnostics & Research
$161.42+$0.38 (+0.24%)
Free research brief
Get the full brief on GH
Free to track. No card required.
Where GH sits today
Price, momentum, and the numbers behind the story.
RSI (14)
50.2Neutral
03070100
Overall score
60/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$105
Current price
$161.42
Median target
$195
Highest
$225
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Current ratio
Strong · Good liquidity position
4.03x
⚠ Things to watch
Price / sales
Rich · Overpriced by revenue
18.31x
ROIC
Weak · Weak capital efficiency
-23.4%
How it stacks up against its peers
GH against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $21.66B | - | +42.7% | 60 |
 | $10.51B | 20.0 | +19.7% | 78 |
 | $33.17B | 34.7 | +15.5% | 78 |
 | $4.12B | 12.4 | +13.5% | 78 |
 | $1.08T | 39.1 | +49.6% | 77 |